Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Hansen Chen, Xi Chen, Yunhao Luo & Jiangang Shen. (2018) Potential molecular targets of peroxynitrite in mediating blood–brain barrier damage and haemorrhagic transformation in acute ischaemic stroke with delayed tissue plasminogen activator treatment. Free Radical Research 52:11-12, pages 1220-1239.
Read now
Read now
G Tan, N Zhu, Z Shi, Z Meng, M Yu, K Li, J Yin, K Wei, X Mi & L Wang. (2015) Anti-high mobility group box 1 (anti-HMGB1) antibodies are not related to the occurrence of cutaneous lesions in systemic lupus erythematosus. Scandinavian Journal of Rheumatology 44:2, pages 150-156.
Read now
Read now
David S. Pisetsky. (2014) The complex role of DNA, histones and HMGB1 in the pathogenesis of SLE. Autoimmunity 47:8, pages 487-493.
Read now
Read now
Oliver Kepp, Laura Senovilla, Ilio Vitale, Erika Vacchelli, Sandy Adjemian, Patrizia Agostinis, Lionel Apetoh, Fernando Aranda, Vincenzo Barnaba, Norma Bloy, Laura Bracci, Karine Breckpot, David Brough, Aitziber Buqué, Maria G. Castro, Mara Cirone, Maria I. Colombo, Isabelle Cremer, Sandra Demaria, Luciana Dini, Aristides G. Eliopoulos, Alberto Faggioni, Silvia C. Formenti, Jitka Fučíková, Lucia Gabriele, Udo S. Gaipl, Jérôme Galon, Abhishek Garg, François Ghiringhelli, Nathalia A. Giese, Zong Sheng Guo, Akseli Hemminki, Martin Herrmann, James W. Hodge, Stefan Holdenrieder, Jamie Honeychurch, Hong-Min Hu, Xing Huang, Tim M. Illidge, Koji Kono, Mladen Korbelik, Dmitri V. Krysko, Sherene Loi, Pedro R. Lowenstein, Enrico Lugli, Yuting Ma, Frank Madeo, Angelo A. Manfredi, Isabelle Martins, Domenico Mavilio, Laurie Menger, Nicolò Merendino, Michael Michaud, Gregoire Mignot, Karen L. Mossman, Gabriele Multhoff, Rudolf Oehler, Fabio Palombo, Theocharis Panaretakis, Jonathan Pol, Enrico Proietti, Jean-Ehrland Ricci, Chiara Riganti, Patrizia Rovere-Querini, Anna Rubartelli, Antonella Sistigu, Mark J. Smyth, Juergen Sonnemann, Radek Spisek, John Stagg, Abdul Qader Sukkurwala, Eric Tartour, Andrew Thorburn, Stephen H. Thorne, Peter Vandenabeele, Francesca Velotti, Samuel T. Workenhe, Haining Yang, Wei-Xing Zong, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Consensus guidelines for the detection of immunogenic cell death. OncoImmunology 3:9.
Read now
Read now
Articles from other publishers (36)
Riley Kahan, Paul L. Cray, Nader Abraham, Qimeng Gao, Matthew G. Hartwig, Justin J. Pollara & Andrew S. Barbas. (2023) Sterile inflammation in liver transplantation. Frontiers in Medicine 10.
Crossref
Crossref
Yu Tian, Rong Chen & Zhaoliang Su. (2021) HMGB1 is a Potential and Challenging Therapeutic Target for Parkinson’s Disease. Cellular and Molecular Neurobiology 43:1, pages 47-58.
Crossref
Crossref
Baptiste Balança, Laurent Desmurs, Jérémy Grelier, Armand Perret-Liaudet & Anne-Claire Lukaszewicz. (2021) DAMPs and RAGE Pathophysiology at the Acute Phase of Brain Injury: An Overview. International Journal of Molecular Sciences 22:5, pages 2439.
Crossref
Crossref
Hany H. Arab, Muhammad Y. Al-Shorbagy & Muhammed A. Saad. (2021) Activation of autophagy and suppression of apoptosis by dapagliflozin attenuates experimental inflammatory bowel disease in rats: Targeting AMPK/mTOR, HMGB1/RAGE and Nrf2/HO-1 pathways. Chemico-Biological Interactions 335, pages 109368.
Crossref
Crossref
Ishnoor Kaur, Tapan Behl, Simona Bungau, Arun Kumar, Vineet Mehta, Dhruv Setia, Md Sahab Uddin, Gokhan Zengin, Lotfi Aleya & Sandeep Arora. (2020) Exploring the therapeutic promise of targeting HMGB1 in rheumatoid arthritis. Life Sciences 258, pages 118164.
Crossref
Crossref
Michele Ferrara, Ginevra Chialli, Lorena Maria Ferreira, Elena Ruggieri, Giorgia Careccia, Alessandro Preti, Rosanna Piccirillo, Marco Emilio Bianchi, Giovanni Sitia & Emilie Venereau. (2020) Oxidation of HMGB1 Is a Dynamically Regulated Process in Physiological and Pathological Conditions. Frontiers in Immunology 11.
Crossref
Crossref
Hee Sue Kim, Myeonggil Han, In Ho Park, Cheol Ho Park, Man Sup Kwak & Jeon-Soo Shin. (2020) Sulfatide Inhibits HMGB1 Secretion by Hindering Toll-Like Receptor 4 Localization Within Lipid Rafts. Frontiers in Immunology 11.
Crossref
Crossref
Runhong Lei, Liben Yan, Yulin Deng, Jin Xu, Tuo Zhao, M. Umer Farooq Awan, Qiang Li, Guangming Zhou, Xiao Wang & Hong Ma. (2020) HMGB1 mediated autophagy protects glioblastoma cells from carbon-ion beam irradiation injury. Acta Astronautica 166, pages 628-634.
Crossref
Crossref
Jerrold S. Levine & David S. Ucker. 2019. Intracellular Signalling Proteins. Intracellular Signalling Proteins
1
90
.
Harriet Gaskell, Xiaodong Ge & Natalia Nieto. (2018) High‐Mobility Group Box‐1 and Liver Disease. Hepatology Communications 2:9, pages 1005-1020.
Crossref
Crossref
Vanesa Stojanovska, Rachel M. McQuade, Sarah Fraser, Monica Prakash, Shakuntla Gondalia, Rhian Stavely, Enzo Palombo, Vasso Apostolopoulos, Samy Sakkal & Kulmira Nurgali. (2018) Oxaliplatin-induced changes in microbiota, TLR4+ cells and enhanced HMGB1 expression in the murine colon. PLOS ONE 13:6, pages e0198359.
Crossref
Crossref
Anja Petrović, Desanka Bogojević, Aleksandra Korać, Igor Golić, Sofija Jovanović-Stojanov, Vesna Martinović, Svetlana Ivanović-Matić, Jelena Stevanović, Goran Poznanović & Ilijana Grigorov. (2017) Oxidative stress-dependent contribution of HMGB1 to the interplay between apoptosis and autophagy in diabetic rat liver. Journal of Physiology and Biochemistry 73:4, pages 511-521.
Crossref
Crossref
Junying Ding, Xuran Cui & Qingquan Liu. (2017) Emerging role of HMGB1 in lung diseases: friend or foe. Journal of Cellular and Molecular Medicine 21:6, pages 1046-1057.
Crossref
Crossref
F Schaper, K de Leeuw, G Horst, F Maas, H Bootsma, P Heeringa, P C Limburg & J Westra. (2017) Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus. Clinical and Experimental Immunology 188:3, pages 412-419.
Crossref
Crossref
Peleg Rider, Elena Voronov, Charles A. Dinarello, Ron N. Apte & Idan Cohen. (2017) Alarmins: Feel the Stress. The Journal of Immunology 198:4, pages 1395-1402.
Crossref
Crossref
D.S. Pisetsky. 2017. Chromatin Remodelling and Immunity. Chromatin Remodelling and Immunity
113
137
.
Annegret Kuhn, Joerg Wenzel & Marc Bijl. (2015) Lupus erythematosus revisited. Seminars in Immunopathology 38:1, pages 97-112.
Crossref
Crossref
Ashok R. AminAbul B.M.M.K. Islam. (2014) Genomic Analysis and Differential Expression of HMG and S100A Family in Human Arthritis: Upregulated Expression of Chemokines, IL-8 and Nitric Oxide by HMGB1. DNA and Cell Biology 33:8, pages 550-565.
Crossref
Crossref
Christina JankoMilos FilipovićLuis E. MunozChristine SchornGeorg SchettIvana Ivanović-BurmazovićMartin Herrmann. (2014) Redox Modulation of HMGB1-Related Signaling. Antioxidants & Redox Signaling 20:7, pages 1075-1085.
Crossref
Crossref
Karin Palmblad, Hanna Schierbeck, Erik Sundberg, Anna-Carin Horne, Helena Erlandsson Harris, Jan-Inge Henter, Daniel J. Antoine & Ulf Andersson. (2014) High Systemic Levels of the Cytokine-Inducing HMGB1 Isoform Secreted in Severe Macrophage Activation Syndrome. Molecular Medicine 20:1, pages 538-547.
Crossref
Crossref
Fleur Schaper, Johanna Westra & Marc Bijl. (2014) Recent Developments in the Role of High-Mobility Group Box 1 in Systemic Lupus Erythematosus. Molecular Medicine 20:1, pages 72-79.
Crossref
Crossref
David S. Pisetsky. (2014) The Expression of HMGB1 on Microparticles Released during Cell Activation and Cell Death In Vitro and In Vivo. Molecular Medicine 20:1, pages 158-163.
Crossref
Crossref
Melinda Magna & David S. Pisetsky. (2014) The Role of HMGB1 in the Pathogenesis of Inflammatory and Autoimmune Diseases. Molecular Medicine 20:1, pages 138-146.
Crossref
Crossref
Yu Chen, Wei Sun, Rongfen Gao, Yuying Su, Hisanori Umehara, Lingli Dong & Feili Gong. (2013) The role of high mobility group box chromosomal protein 1 in rheumatoid arthritis. Rheumatology 52:10, pages 1739-1747.
Crossref
Crossref
Liang Feng, Maomao Zhu, Minghua Zhang, Junfei Gu, Xiaobin Jia, Xiaobin Tan, Chenglin Gao & Quan Zhu. (2013) The protection of 4,4′-diphenylmethane-bis(methyl) carbamate from Cortex Mori on advanced glycation end product-induced endothelial dysfunction: Via inhibiting AGE formation or blocking AGEs–RAGE axis?. Fitoterapia 89, pages 239-249.
Crossref
Crossref
DA Abdulahad, J Westra, E Reefman, E Zuidersma, J Bijzet, PC Limburg, CGM Kallenberg & M Bijl. (2013) High mobility group box1 (HMGB1) in relation to cutaneous inflammation in systemic lupus erythematosus (SLE). Lupus 22:6, pages 597-606.
Crossref
Crossref
Liang Feng, Maomao Zhu, Minghua Zhang, Xiaobin Jia, Xudong Cheng, Shumin Ding & Quan Zhu. (2013) Amelioration of compound 4,4′-diphenylmethane-bis(methyl)carbamate on high mobility group box1-mediated inflammation and oxidant stress responses in human umbilical vein endothelial cells via RAGE/ERK1/2/NF-κB pathway. International Immunopharmacology 15:2, pages 206-216.
Crossref
Crossref
Emilie Venereau, Maura Casalgrandi, Milena Schiraldi, Daniel J. Antoine, Angela Cattaneo, Francesco De Marchis, Jaron Liu, Antonella Antonelli, Alessandro Preti, Lorenzo Raeli, Sara Samadi Shams, Huan Yang, Luca Varani, Ulf Andersson, Kevin J. Tracey, Angela Bachi, Mariagrazia Uguccioni & Marco E. Bianchi. (2012) Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. Journal of Experimental Medicine 209:9, pages 1519-1528.
Crossref
Crossref
M-L Gougeon, M-T Melki & H Saïdi. (2011) HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells. Cell Death & Differentiation 19:1, pages 96-106.
Crossref
Crossref
Michela VezzoliPatrizia CastellaniGianfranca CornaAlessandra CastiglioniLidia BosurgiAntonella MonnoSilvia BrunelliAngelo A. ManfrediAnna RubartelliPatrizia Rovere-Querini. (2011) High-Mobility Group Box 1 Release and Redox Regulation Accompany Regeneration and Remodeling of Skeletal Muscle. Antioxidants & Redox Signaling 15:8, pages 2161-2174.
Crossref
Crossref
V. Urbonaviciute & R. E. Voll. (2011) High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus. Journal of Internal Medicine 270:4, pages 309-318.
Crossref
Crossref
Semi Park & Stephen J. Lippard. (2011) Redox State-Dependent Interaction of HMGB1 and Cisplatin-Modified DNA. Biochemistry 50:13, pages 2567-2574.
Crossref
Crossref
Daolin TangRui KangHerbert J. ZehIIIIIIMichael T. Lotze. (2011) High-Mobility Group Box 1, Oxidative Stress, and Disease. Antioxidants & Redox Signaling 14:7, pages 1315-1335.
Crossref
Crossref
Chloé Borde, Stéphanie Barnay-Verdier, Claire Gaillard, Hakim Hocini, Vincent Maréchal & Joël Gozlan. (2011) Stepwise Release of Biologically Active HMGB1 during HSV-2 Infection. PLoS ONE 6:1, pages e16145.
Crossref
Crossref
Alessandra Castiglioni, Valentina Canti, Patrizia Rovere-Querini & Angelo A. Manfredi. (2010) High-mobility group box 1 (HMGB1) as a master regulator of innate immunity. Cell and Tissue Research 343:1, pages 189-199.
Crossref
Crossref
D.A. Abdulahad, J. Westra, P.C. Limburg, C.G.M. Kallenberg & M. Bijl. (2010) HMGB1 in systemic lupus Erythematosus: Its role in cutaneous lesions development. Autoimmunity Reviews 9:10, pages 661-665.
Crossref
Crossref